rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Community Health Systems, Inc.

CYH · NYSE

Health CareProviders & FacilitiesNot moving yet

CYH stood above a rising 150-day average in 8 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 4.1% below that average now. Providers & Facilities: 47% of its 53 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 13
Industry in uptrend
47% -2 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$237K
Officials’ trades on record
0
Institutions holding
171 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 8 of 52 weeks.

21 Apr – 20 Oct
27%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$228K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1
WhoDidSharesTraded
William Norris JenningsDirectorsold40,000at $2.9625 Aug 2026filed 25 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders171+9 on the quarter
New · exited31 · 22
Reported value$384.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CastleKnight Management LPadded · filed 14 Aug 202613,384,586$44.7M+717,000+5.7%
Apollo Management Holdings, L.P.added · filed 14 Aug 202611,859,526$39.6M+370,210+3.2%
BlackRock, Inc.added · filed 7 Aug 202610,930,538$36.5M+1,127,681+11.5%
Eversept Partners, LPreduced · filed 14 Aug 20267,864,575$26.3M-812,706−9.4%
NOMURA HOLDINGS INCreduced · filed 14 Aug 20266,703,109$22.4M-181,900−2.6%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20265,289,931$17.7M-85,572−1.6%
WHITEBOX ADVISORS LLCadded · filed 14 Aug 20263,732,743$12.5M+604,859+19.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20263,167,702$10.6M+260,097+8.9%
STATE STREET CORPadded · filed 7 Aug 20263,061,863$10.2M+139,953+4.8%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20263,018,598$10.1M+25,102+0.8%
31 Mar 2023 – 30 Jun 2026
150160170Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

William Norris Jennings Company insiderDirector · last 25 Aug 20260 · 4
K. Ranga Krishnan Company insiderDirector · last 30 Jun 20260 · 0
David Rice V Company insiderEVP-Clinical Operations & CMO · last 1 Jun 20260 · 0
Wayne T. Smith Company insiderDirector · last 2 Mar 202611 · 14
Elizabeth T. Hirsch Company insiderDirector · last 1 Mar 20260 · 0
Fawn D. Lopez Company insiderDirector · last 1 Mar 20260 · 0
Hubert James Williams Company insiderDirector · last 1 Mar 20260 · 0
James S. Ely III Company insiderDirector · last 1 Mar 20267 · 0
Jason K. Johnson Company insiderEVP & CFO · last 1 Mar 20260 · 0
John A. Clerico Company insiderDirector · last 1 Mar 20261 · 0
John A. Fry Company insiderDirector · last 1 Mar 20260 · 5
Joseph Arthur Hastings Company insiderDirector · last 1 Mar 20260 · 0

Same industry

PACS PACS GroupLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202585.1%
Operating profit marginFY 2025 · to 31 Dec 202511.9%
Free cash flow marginFY 2025 · to 31 Dec 20251.7%
Return on capital employedFY 2025 · to 31 Dec 202513.5%
Cash conversionFY 2025 · to 31 Dec 2025107%
Share count trendFY 2025 · to 13 Feb 2026-0.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$260.0M
Free cash flowFY 2025 · to 31 Dec 2025$208.0M

Analyst forecasts

No analyst forecasts yet.